These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2126144)

  • 21. A double-blind, randomized comparison of fluvoxamine with mianserin in depressive illness.
    Perez A; Ashford JJ
    Curr Med Res Opin; 1990; 12(4):234-41. PubMed ID: 2127561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression.
    Lydiard RB; Laird LK; Morton WA; Steele TE; Kellner C; Laraia MT; Ballenger JC
    Psychopharmacol Bull; 1989; 25(1):68-70. PubMed ID: 2505304
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparison of adinazolam and desipramine in the treatment of major depression.
    Kennedy SH; de Groot J; Ralevski E; Reed K
    Int Clin Psychopharmacol; 1991; 6(2):65-76. PubMed ID: 1960382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the efficacy and safety of alprazolam and desipramine in depressed outpatients.
    Remick RA; Keller FD; Buchanan RA; Gibson RE; Fleming JA
    Can J Psychiatry; 1988 Oct; 33(7):590-4. PubMed ID: 3058290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people.
    Phanjoo AL; Wonnacott S; Hodgson A
    Acta Psychiatr Scand; 1991 Jun; 83(6):476-9. PubMed ID: 1909083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluvoxamine treatment of obsessive-compulsive disorder.
    Perse TL; Greist JH; Jefferson JW; Rosenfeld R; Dar R
    Am J Psychiatry; 1987 Dec; 144(12):1543-8. PubMed ID: 3120604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo.
    Goodman WK; Price LH; Rasmussen SA; Delgado PL; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1989 Jan; 46(1):36-44. PubMed ID: 2491940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data.
    Wakelin JS
    Int Clin Psychopharmacol; 1986 Jul; 1(3):221-30. PubMed ID: 3104446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study.
    Gonella G; Baignoli G; Ecari U
    Curr Med Res Opin; 1990; 12(3):177-84. PubMed ID: 2125547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluvoxamine versus desipramine: comparative polysomnographic effects.
    Kupfer DJ; Perel JM; Pollock BG; Nathan RS; Grochocinski VJ; Wilson MJ; McEachran AB
    Biol Psychiatry; 1991 Jan; 29(1):23-40. PubMed ID: 1900443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind, placebo-controlled study of paroxetine in depressed outpatients.
    Kiev A
    J Clin Psychiatry; 1992 Feb; 53 Suppl():27-9. PubMed ID: 1531818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: a double-blind, multicentre study. The LUCIFER Group.
    Haffmans PM; Timmerman L; Hoogduin CA
    Int Clin Psychopharmacol; 1996 Sep; 11(3):157-64. PubMed ID: 8923094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment outcome validation of DSM-III depressive subtypes. Clinical usefulness in outpatients with mild to moderate depression.
    Stewart JW; McGrath PJ; Liebowitz MR; Harrison W; Quitkin F; Rabkin JG
    Arch Gen Psychiatry; 1985 Dec; 42(12):1148-53. PubMed ID: 3907579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin reuptake inhibition vs. norepinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives.
    Emrich HM; Berger M; Riemann D; von Zerssen D
    Pharmacopsychiatry; 1987 Mar; 20(2):60-3. PubMed ID: 3108909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clovoxamine in the treatment of depressed outpatients: a double-blind, parallel-group comparison against amitriptyline and placebo.
    Gelenberg AJ; Wojcik JD; Falk WE; Spring B; Brotman AW; Galvin-Nadeau M
    Compr Psychiatry; 1990; 31(4):307-14. PubMed ID: 2201481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The tolerance and antidepressive activity of fluvoxamine as a single dose compared to a twice daily dose.
    Siddiqui UA; Chakravarti SK; Jesinger DK
    Curr Med Res Opin; 1985; 9(10):681-90. PubMed ID: 3935377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Which depressions respond to placebo?
    Fairchild CJ; Rush AJ; Vasavada N; Giles DE; Khatami M
    Psychiatry Res; 1986 Jul; 18(3):217-26. PubMed ID: 3529150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term study of fluvoxamine: a new rapid-acting antidepressant.
    Feldmann HS; Denber HC
    Int Pharmacopsychiatry; 1982; 17(2):114-22. PubMed ID: 6809683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind comparison of clovoxamine and amitriptyline in the treatment of depressed outpatients.
    Gelenberg AJ; Wojcik JD; Newell C; Lamping DL; Spring B
    J Clin Psychopharmacol; 1985 Feb; 5(1):30-4. PubMed ID: 3882774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy and safety of paroxetine compared with placebo in outpatients with major depression.
    Rickels K; Amsterdam J; Clary C; Fox I; Schweizer E; Weise C
    J Clin Psychiatry; 1992 Feb; 53 Suppl():30-2. PubMed ID: 1531820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.